Follow-up | n = 40 |
---|---|
Angiographic follow-up | 13 (32.5%) |
Angiographic follow-up indication | |
Stable angina | 8 (9%) |
Unstable angina | 3 (7.5%) |
STEMI | 1 (2.5%) |
NSTEMI | 1 (2.5%) |
% diameter stenosis of MV in case of angio follow-up | 2.9 ± 3.4% |
% diameter stenosis of SB | 11 ± 29.49% |
Average duration from index procedure to the last follow-up (days) | 444 ± 303 |
Binary restenosis MV | 0% |
Binary restenosis SB | 1 (2.5%) |
MV MLD | 3.2 ± 0.47 mm |
SB MLD | 1.784 ± 0.6 mm |
MV TLR | 0% |
SB TLR | 0% |
Aspirin at follow-up | 40 (100%) |
P2Y12 inhibitors at follow-up | 25 (62.5%) |
Death | 0% |
CV death | 0% |
Non CV death | 0% |
TV MI | 1 (2.5%) |
TV MI management | POBA |
TLR | 0% |
TVR | 1(2.5%) |
Date of TVR | 10-4-2014 |
TLR or TVR management | POBA |
TL thrombosis | 0% |